Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

806 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 401–450 of 806 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02893930	Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery	completed	Phase 2	13	National Cancer Institute (NCI)NIH	1	Oct 17, 2023	clinicaltrials
NCT05871320	Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms(TECANT)	completed	Early Phase 1	10	Jagiellonian UniversityOTHER	3	Sep 29, 2023